Peptide Allergies and Reactions

Immediate hypersensitivity (Type I): IgE-mediated, occurs within minutes to hours. Symptoms: rash, itching, swelling, difficulty breathing, anaphylaxis. Delayed hypersensitivity (Type IV): cell-mediated, develops over hours to days.

Peptides themselves are often not highly allergenic. Contamination with bacterial proteins or manufacturing residues can trigger allergic responses.

Prior exposure to the same or similar peptide. Existing allergic conditions or atopic predisposition. Contamination in the sample. The route of administration (injection is higher risk than other routes).

Individual variation in immune response means similar doses produce different reactions in different people.

Anaphylaxis is a severe, rapid allergic reaction that requires immediate medical attention. It is rare with purified peptides but possible, especially with injection. Signs include difficulty breathing, throat tightness, severe drop in blood pressure.

Injectable peptides carry higher anaphylaxis risk than other routes. Medical supervision is essential for injectables.

Pure, contaminant-free peptides have low allergenic risk compared to contaminated samples. The route of administration matters — injection carries higher risk than oral. Prior exposure matters — novel peptides have unknown risk.